Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
54.95-0.59 (-1.06%)
At close: 04:02PM EST
55.03 +0.08 (+0.15%)
After hours: 07:59PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.62
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 361.71
52 Week Low 333.36
50-Day Moving Average 354.05
200-Day Moving Average 344.89

Share Statistics

Avg Vol (3 month) 342.7M
Avg Vol (10 day) 339.23M
Shares Outstanding 55.61B
Implied Shares Outstanding 6N/A
Float 85.61B
% Held by Insiders 10.04%
% Held by Institutions 167.43%
Shares Short (Dec 14, 2021) 466.01M
Short Ratio (Dec 14, 2021) 41.5
Short % of Float (Dec 14, 2021) 41.18%
Short % of Shares Outstanding (Dec 14, 2021) 41.18%
Shares Short (prior month Nov 14, 2021) 463.54M

Dividends & Splits

Forward Annual Dividend Rate 41.6
Forward Annual Dividend Yield 42.93%
Trailing Annual Dividend Rate 31.55
Trailing Annual Dividend Yield 32.79%
5 Year Average Dividend Yield 43.67
Payout Ratio 445.06%
Dividend Date 3Mar 03, 2022
Ex-Dividend Date 4Jan 26, 2022
Last Split Factor 21054:1000
Last Split Date 3Nov 16, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Oct 02, 2021

Profitability

Profit Margin 28.68%
Operating Margin (ttm)32.14%

Management Effectiveness

Return on Assets (ttm)7.78%
Return on Equity (ttm)27.75%

Income Statement

Revenue (ttm)69.34B
Revenue Per Share (ttm)12.41
Quarterly Revenue Growth (yoy)134.40%
Gross Profit (ttm)33.33B
EBITDA 27.31B
Net Income Avi to Common (ttm)19.57B
Diluted EPS (ttm)3.50
Quarterly Earnings Growth (yoy)454.50%

Balance Sheet

Total Cash (mrq)29.7B
Total Cash Per Share (mrq)5.29
Total Debt (mrq)39.88B
Total Debt/Equity (mrq)52.50
Current Ratio (mrq)1.38
Book Value Per Share (mrq)13.49

Cash Flow Statement

Operating Cash Flow (ttm)32.29B
Levered Free Cash Flow (ttm)42.43B
Advertisement
Advertisement